Earnings Analysis of: Morgan Stanley (NYSE:MS)

Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. First Manhattan Co. increased its position in shares of Morgan Stanley by 2.4% in the third quarter. Salem Investment Counselors Inc. bought a new stake in shares of Morgan Stanley during the third quarter worth $110,000. The stock spiked 10.8% last month and is up 10.54 this year. Commerzbank Aktiengesellschaft FI boosted its position in shares of Morgan Stanley by 28.1% in the second quarter. First Manhattan Co. boosted its stake in shares of Morgan Stanley by 2.4% in the third quarter. Acrospire Investment Management LLC now owns 6,200 shares of the financial services provider's stock valued at $161,000 after buying an additional 3,100 shares during the last quarter.

Morgan Stanley (NYSE:MS) belonging to the Finance sector has surged 0.98% and closed its last trading session at $46.49. The shares were sold at an average price of $42.30, for a total transaction of $12,048,182.10. After trading began at $45.19 the stock was seen hitting $46.26 as a peak level and $45.1 as the lowest level. The company has a 50-day moving average of $40.19 and a 200 day moving average of $32.30. Company price to earnings (P/E) ratio, which measures the relationship between the earnings of a company and its stock price, is calculated as 15.90.

Morgan Stanley (NYSE:MS) last released its earnings results on Wednesday, October 19th.

Morgan Stanley (MS) surprised the stock market in its last reported earnings when it earned $0.81 a piece versus the consensus-estimated $0.65. The company beat the analyst EPS Estimate with the difference of $0.16. Morgan Stanley had a return on equity of 8.48% and a net margin of 15.76%. They are projecting Next Quarter growth of 14.7%. Stock analysts expect it to report per-share earnings of $0.90 in that period.

A number of research analysts recently commented on the company. Number of analysts are covering this stock and now stock has got OUTPERFORM rating from 1 analyst of Thomson Reuters, 5 analysts given HOLD rating to the stock and 0 given UNDERPERFORM rating.

Morgan Stanley sold the product to retirement account holders, who held the funds long-term. Finally, CLSA restated a "buy" rating and issued a $54.00 target price on shares of Morgan Stanley in a research note on Friday, January 13th.

Some buy side analysts are also providing their Analysis on Morgan Stanley, where 5 analysts have rated the stock as Strong buy, 11 analysts have given a Buy signal, 13 said it's a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. Morgan Stanley now has an average rating of "Buy" and an average target price of $38.05.

Insider Trades for Morgan Stanley show that the latest trade was made on 7 Feb 2017 where Kelleher (Thomas Colm), the President completed a transaction type "Sell" in which 182027 shares were traded at a price of $43.82. Last year, it had about $7.79 billion of revenue. The stock has Return on Assets (ROA) of 0 percent. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

In other news, Chairman James P. Gorman sold 284,827 shares of Morgan Stanley stock in a transaction that occurred on Thursday, January 19th. Commerzbank Aktiengesellschaft FI now owns 1,344,404 shares of the financial services provider's stock valued at $34,928,000 after buying an additional 294,902 shares during the period.

The US Securities and Exchange Commission's order found that Morgan Stanley did not adequately implement its policies and procedures to ensure that clients understood the risks involved with purchasing inverse ETFs. The Company is a global financial services firm that, through its subsidiaries and affiliates, advises, and originates, trades, manages and distributes capital for, governments, institutions and individuals.

What directions Annaly Capital Management, Inc. (NYSE:NLY) insiders are heading
Michigan Basketball Instant Recap: Michigan 64, Wisconsin 58